Friday, October 18, 2019

Vertically Integrated #Cannabis Consumer Packaged goods Company 1933 Industries (CSE: $TGIF.C) (OTCQX: $TGIFF) Corporate Update; @1933Industries

                                                      
Vertically Integrated #Cannabis Consumer Packaged goods Company 1933 Industries (CSE: $TGIF.C) (OTCQX: $TGIFF) Corporate Update; @1933Industries



VANCOUVER, B.C., CANADA- October 18, 2019 - (Investorideas.com Newswire) I933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company, is pleased to provide an update regarding its operations.


Highlights:
  • ·        1933 Industries continues to focus its operations in the licensed US cannabis industry as a multi-state operator in Nevada, Colorado and California.
  • ·        1933 Industries is a two-year old company built with sustainability and profitability as its primary goals and continues to execute on its growth plan. 
  • ·        The Company has instituted capital efficient practices to operate a lean and sustainable business with scalable profitability as its main objective.
  • ·        The Company maintains a strong balance sheet with cash on hand to fund capital projects, the ability to service its debenture payments and currently holds no other debt.
  • ·        Experienced in the cannabis industry, the operationally focused management team raised approximately $36M over the last two years and has added $60M in assets to the Company.
  • ·        Three major capital projects were undertaken by management in order to build expanded infrastructure capacity for cannabis flower cultivation, production of concentrates, and hemp-derived CBD extraction in Nevada.
  • ·        Cultivation facility in Las Vegas was completed and the first harvest is now expected in December, bringing a 5-fold increase in flower production and raw materials for cannabis concentrates.
  • ·        New manufacturing facility in California is coming online in November as well as expanded cultivation capacity for the Company’s AMA premium flower brand.
  • ·        The Company’s proprietary Canna Hemp™ wellness line continues to establish itself as a premier CBD brand across the US and is now available in over 800 retail outlets.
  • ·        World-renowned brands such as OG DNA Genetics, and The Original Jack Herer® selected the Company’s subsidiary, Alternative Medicine Association, as their exclusive partner in Nevada, as well as luxury brand Blonde™ Cannabis, leading concentrate producer Denver Dab Co., premium cannabis brand Gotti’s Gold and custom hardware manufacturer PLUGplay.
  • ·        Leading specialty retailer Zumiez is now carrying the Company’s CBD Canna Hemp X™ sports cream, which was launched in collaboration with top skateboarding company Grizzly Griptape.
  • ·        The exclusive Birdhouse Skateboards™/Canna Hemp X™ co-branded sports cream is set to launch in November and will be available at US Zumiez stores.


Fiscal Responsibility, Strong Balance Sheet and Cash Position
The Company recently provided guidance on its Q4 financial results (see news release dated September 12, 2019) and will be announcing its Annual Financial Report by the regulatory deadline of November 30th.

1933 Industries is a two-year old company built with sustainability and profitability as its primary goals and continues to execute on its growth plan.  The Company sold its purpose-built cultivation facility and negotiated a 10-year lease-back agreement to operate one of Nevada’s largest indoor cultivation facilities for premium craft cannabis (see news release dated May 15, 2019). Gross proceeds of $10.45M are being utilized to fund infrastructure projects in Nevada and California, to open new markets in Arizona and Colorado, and to continue the expansion of its Canna Hemp™ consumer branded goods across the US. Management has built significant sequential growth, quarter after quarter, year over year, building a continued path towards profitability once all projects become fully operational. Additionally, the Company has streamlined its business units to significantly improve operational efficiencies across and reduce corporate overhead.

Expanding Cultivation Capacity in Nevada and California
The Company recently reported that it expects the first harvest of high premium flower from its new cultivation facility in Las Vegas in December, with subsequent harvests every two-weeks thereafter (news release dated September 302019). The completion of the 67,750 sq. ft. purpose-built, indoor facility was a major milestone for the Company as it positions itself as the largest wholesale supplier of premium craft flower to licensed dispensaries and ensures the consistent supply of raw materials for the Company’s AMA product line and licensing partners. The expected output of 700 lbs. of cannabis flower is a 5-fold increase in production and the Company expects that all flower rooms will be filled and harvesting on a continuing basis by January, 2020.

The cultivation and manufacturing buildout in California is on schedule to be completed by the end of October and will be in production by November. The California operation is managed by the Company, but owned by a third party (news release dated August 15, 2019). Both the Nevada and California facilities bring almost 80,000 sq. ft. of total cultivation space to the Company while positioning the Company to maximize cultivation and extraction capabilities in both states.

New Extraction Facilities in Progress
The Company reports that the renovation to increase the footprint of its current extraction facility is on track to receive construction permits from Clark County this week. The construction will take three months to complete, which will double the Company’s extraction and production capabilities (news release dated July 12, 2019).

The Company’s hemp-derived cannabidiol (CBD) extraction facility (Hemp Lab) under development is being designed with the capacity to isolate cannabinoids such as CBD, CBN and CBG, at commercial scale volumes in order to utilize all isolates in the manufacturing of the Company’s own proprietary branded products, with the aim of increasing product margins and bringing online a new, recurring revenue stream. The Company will be providing a full update on its Hemp Lab once it finalizes the timing of equipment delivery, county approvals and engineering plans.

Positioning Canna Hemp as the Premier CBD product line in the US
As a brand-focused company, building a strong portfolio of high margin, industry-leading brands that have wide appeal to consumers is a key priority for the Company. With wholesale partnerships, nationwide reach of its products, and a new partnership with Zumiez retailer in the US, the Company has added an e-Commerce channel with a revamped website portal and upcoming marketing campaigns targeting mainstream media.

The Company’s sports cream, Canna Hemp X™, a collaboration with Grizzly Griptape, targets a growing consumer following from the skateboarding, BMX, snowboarding, motocross and MMA fields of sport. Working through brand ambassadors in all the above sports, the Company is building a brand that resonates with athletes of all levels. The Company has executed licensing agreements with best of breed names including Grizzly Griptape and Birdhouse Skateboards™, with the latter soon to launch a co-branded Birdhouse/Canna Hemp X™ CBD Balm in November. Marketing campaigns will include skateboarding legend Mr. Tony Hawk, Mr. Clive Dixon, Mr. David Loy as well as other Birdhouse team riders to promote the collaboration.  The Company continues to build on its ambassador and influencer programs, with the aim to build teams across the main focus sports noted above.

Management Commentary
Mr. Chris Rebentisch, CEO of the Company remarked, “We are pleased to report that we have never been in a stronger position as a company. We are fully capitalized to execute on our strategy, without having to raise capital and with no debt in our books. With multiple projects coming online over the next months that will increase revenues, we will continue to build our strongest brand portfolio to date while we work towards profitability. We confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity. The current share price is not representative of the performance of our operations.”

Mr. Brayden Sutton, Chairman of the Board added, “We have a solid balance sheet that demonstrates the strength of the management team and its expertise as operators in the cannabis space with a long history of execution in the consumer packaged goods sector. We continue to build one of the most impressive ‘House of Brands’ in the market with increasing revenues and distribution. We are in the enviable position to weather market pressures until the sector recovers, and we believe that in the changing landscape of the cannabis industry, companies such as ours with strong fundamentals will become the next phase of the cannabis industry, one that will be distinguished by quality products, safety of ingredients and brand affinity.”

About 1933 Industries Inc. 
1933 Industries Inc. is a vertically integrated, brand-focused cannabis company with operations in the United States and Canada. Operating through two subsidiary companies, the Company owns leading cannabis brands as well as licensed cannabis cultivation, extraction, processing and manufacturing assets.

Our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates, CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™. Partners under licensing agreements include Birdhouse Skateboards™, Blonde™ Cannabis, Denver Dab Co., Gotti’s Gold, Grizzly Griptape, OG DNA Genetics, PLUGplay, and The Original Jack Herer®.

The Company owns 91% of Alternative Medicine Association, LLC (AMA), and 100% of Infused MFG LLC.

About Canna Hemp™
Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018.

About Canna HempX™
Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance.

For further information please contact:Alexia Helgason, IR and Corporate Communications Director
604-674-4756 (ext. 1)
alexia@1933industries.com
Chris Rebentisch, CEO & Director
604-674-4756 (ext. 1)

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct.  Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.   1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
                                                                       
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this is a paid for news release on Investorideas.com ( $750)
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com  
800-665-0411




Get more Cannabis stock investor ideas- news, articles, podcasts and stock directories





Thursday, October 17, 2019

#CryptoCorner: Bank of America (NYSE: $BAC) Testing Ripple DLT, France’s Finance Minister Pens Op-Ed Criticizing Libra (NASDAQ: $FB), BIGG (CSE: $BIGG.C) Reports on Netcoins Milestones


#CryptoCorner:  Bank of America (NYSE: $BAC) Testing Ripple DLT, France’s Finance Minister Pens Op-Ed Criticizing Libra (NASDAQ: $FB), BIGG (CSE: $BIGG.C) Reports on Netcoins Milestones




Point Roberts, WA, Delta BC October 17, 2019 -  Investorideas.com, a leader in crypto and blockchain investing news brings you today’s edition of the Crypto Corner podcast and commentary on what’s driving the cryptocurrency market .

Listen to today’s Crypto Corner Podcast:  



Stocks discussed: (NYSE:BAC) (NasdaqGS:FB) (CSE:BIGG)

Bank of America (NYSE:BAC) is testing out Ripple’s distributed ledger technology, according to a report from CoinDesk today. A Ripple spokesperson told CoinDesk:

“Bank of America has been part of Ripple’s Global Payment Steering Group since 2016 and we did a pilot with them.”

Bank of America’s membership in this group positions it to advise on rules and standards for Ripplenet, the network of financial institutions using Ripple products. Additionally, the recent report of a job listing for Treasury Product Manager – which includes the responsibility of leading “the product management team for the Ripple Project” – may indicate that the bank is developing a considerable interest in blockchain technology.

French finance minister Bruno Le Maire wrote on op-ed for the Financial Times, in which he cautioned against Facebook’s (NasdaqGS:FB) Libra. Le Maire warned that currencies from a private firm like Facebook risked undermining state-controlled fiat currencies. He wrote:

“France’s position is clear: we want financial innovation to respect the sovereignty of states. Neither political nor monetary sovereignty can be shared with private interests.”

He followed up the op-ed with the following tweet:

“#Libra does not only raise issues of security and financial stability. Libra is actually asking states to share monetary sovereignty with a private company. This is unacceptable!”

Messaging service Telegram will delay the launch of its Telegram Open Network (TON) blockchain project, according to Cointelegraph. This was instigated by a recent U.S. Securities and Exchanges Commission (SEC) conclusion that Telegram’s $1.7 billion dollar token offering was illegal. The firm has a hearing scheduled with regulators in New York on Oct. 24, where it will challenge the SEC’s decision. In the meantime, Telegram sent a letter to investors regarding the moving of the launch deadline.

BIGG Digital Assets, Inc. (CSE:BIGG) has provided an update on its wholly-owned subsidiary, crypto brokerage platform Netcoins. According to the press release, Netcoins achieved a lifetime milestone of processing $125 million in transactions since inception via online brokerage, virtual ATM and OTC services. The platform also processed some $59 million in transactions in 2018 and is tracking to $69 million for the first three quarters of 2019. Netcoins president Mitchell Demeter commented:

“We are thrilled to now be part of the BIGG Digital Assets family. Crypto winter seems to have thawed out, and Netcoins has continued to evolve in order to take full advantage of the next bull run in crypto. With a compliance first approach, we want to ensure that every customer’s money is safe and that the platform meets their needs in every way. Through new banking relationships, and the financial backing of BIGG, Netcoins is well positioned for growth into 2020 and beyond.” 

Sam Mowers, Investorideas

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .


The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Cryptocurrency Disclaimer
Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Copyright and ownership: Crypto Corner is an Investorideas.com content brand

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800-665-0411



Get more Bitcoin and Blockchain Investor ideas  – news, articles, podcasts and stock directories 



The #AIEye: IBM (NYSE: $IBM) Joins Mayflower Autonomous Ship Project, Microsoft (Nasdaq: $MSFT) and Nuance (Nasdaq: $NUAN) Work Together to Accelerate Ambient Clinical Intelligence

The #AIEye: IBM (NYSE: $IBM) Joins Mayflower Autonomous Ship Project, Microsoft (Nasdaq: $MSFT) and Nuance (Nasdaq: $NUAN) Work Together to Accelerate Ambient Clinical Intelligence

Global #AI in Fashion Market to Reach $1.26 Billion USD by 2024




Point Roberts WA, Vancouver BC – October 17, 2019  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:



Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NYSE:IBM) (NasdaqGS:MSFT) (NasdaqGS:NUAN)

IBM (NYSE:IBM) has joined a global consortium of partners, led by marine research organization ProMare, that are building an unmanned, fully-autonomous ship that will cross the Atlantic on the fourth centenary of the original Mayflower voyage in September 2020. Called the Mayflower Autonomous Ship (MAS), it will leverage IBM technology, including AI, to “navigate autonomously and avoid ocean hazards as it makes its way from Plymouth, England to Plymouth, Massachusetts”. Andy Stanford-Clark, Chief Technology Officer, IBM UK & Ireland, commented:

"IBM helped put man on the moon and is excited by the challenge of using advanced technologies to cross and research our deepest oceans. By providing the brains for the Mayflower Autonomous Ship, we are pushing the boundaries of science and autonomous technologies to address critical environmental issues."

Microsoft (NasdaqGS:MSFT) and Nuance Communications, Inc. (NasdaqGS:NUAN) have joined to accelerate the delivery of ambient clinical intelligence (ACI) technologies and transform healthcare. Nuance’s Dragon Medical platform, conversational AI and voice biometrics will work in tandem with Microsoft Azure AI and natural language processing to “deliver a seamless and engaging interaction between clinicians and patients”. Dr. James Linder, CEO of Nebraska Medicine, said:

"Physician burnout has become one of the most important concerns facing the healthcare industry today. We're excited about the early results of ACI to help clinicians focus more on patients. We look forward to the innovations our two trusted partners, Nuance and Microsoft, will deliver together."

Global AI in Fashion Market to Reach $1.26 Billion USD by 2024

A report from Markets and Markets finds that the global AI in Fashion market will grow from $228 million in 2019 to $1.26 billion by 2024 with a compound annual growth rate (CAGR) of 40.8 percent in the forecast period. An excerpt from the report’s press release reads:

With the rising adoption of social media and increasing customer awareness, fashion retailers are trying to provide every best possible service to their customers to enhance trust and hold them for a longer time. Hence, product recommendation has become important to engage customers in an effective way with the growing online sales trends, fashion retailers have started deploying AI-powered recommendation systems in order to make personalized product recommendations based on shoppers buying history, style, taste, and preferences. Therefore, the growth of this application would continue to grow during the forecast period.

Fashion stores include online fashion stores and offline fashion stores that have started deploying AI technologies into their operations. The fashion store end-user segment is estimated to account for the largest size during the forecast period. Increasing deployment of cloud-based AI-powered solution by fashion retailers has enabled brands to gain a competitive advantage over other players.

Sam Mowers, Investorideas.com

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800 665 0411

  



Get more tech stocks investor ideas- news, articles, podcasts  and stock directories



Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Happy 1 Year Anniversary Canada! (NYSE: $ACB) (TSXV: $GYSR.V) (CSE: $BOSS.C) (TSXV: $NRTH.V) (NASDAQ: $NEPT) (CSE: $SOL.C) (NEO: CCHW)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Happy 1 Year Anniversary Canada! (NYSE: $ACB) (TSXV: $GYSR.V) (CSE: $BOSS.C) (TSXV: $NRTH.V) (NASDAQ: $NEPT) (CSE: $SOL.C) (NEO: CCHW)



Delta, Kelowna, BC –October 17, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts

In today’s podcast we look today’s early announcements.

Aurora Cannabis Inc. (NYSE: ACB(TSX: ACB) announced its plans for the roll-out of vapes, concentrates, and edibles when they are permitted for sale to consumers in December. The Company has prioritized its resources to prepare for a successful initial launch that will support an ongoing replenishment strategy to help ensure consumers across Canada will have access to a diverse portfolio of high-quality derivative products they want to buy.

You can watch a compilation of our commercial production of vapes, mints, chocolates and gummies HERE.
Photos are available on Aurora's Investor website HERE.

"Aurora's Product Development and Insights teams have done tremendous work to formulate new products in a variety of formats that we think will exceed consumer expectations and drive category growth," said Aurora CEO Terry Booth. "Aurora has built industry-leading cannabis capacity and scalability supported by our consumer research and retail distribution bench strength to launch this next generation of cannabis products into the Canadian market. We are ready to ship product as soon as the regulations allow and are excited for consumers and patients to finally have access to a greater selection of product forms. We are already working on expanding the range of new products beyond those that will initially launch."

To support the successful launch of vapes, concentrates, and edibles products, and to continue to ensure sufficient supply for domestic and international markets, Aurora has established production hubs in Eastern and Western Canada at Aurora River (Bradford, Ontario), Aurora Vie (Pointe Claire, Quebec) and at Aurora Sky (Leduc, Alberta).
These centres are intended to provide centralized production, packaging, logistics and distribution capabilities. In total, they comprise more than 450,000 square feet and are strategically located to efficiently distribute Aurora's products to markets across the country. In addition, Aurora Air, a 20,000 square foot manufacturing facility near Aurora Sky at the Edmonton International Airport, will be home to several of the new production lines for edible products. Aurora's next generation products have been formulated to meet or exceed all regulatory requirements. All new cannabis product forms are subject to a legislated Health Canada 60-day review period that begins on October 17, 2019.

Geyser Brands Inc. (formerly Kanzen Capital Corp.) (TSX-V: GYSRannounced that its subsidiary, 0957102 B.C. Ltd. DBA Apothecary Botanicals, is preparing to commence its co-packing and manufacturing operations as a means to grow Geyser Brands' in-house brands, as well as bolster its operations by partnering with third-party consumer-packaged goods brands, to bring cannabis to the mainstream in the health and wellness sector.

Apothecary Botanicals has signed a non-binding letter of intent to enter into a co-packing agreement between Geyser Brands' subsidiary, Apothecary Botanicals, and The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), for the production and launch of Yield Growth's Canadian cannabis brand 'Jack n Jane', a line of cannabis-infused products including tinctures, topicals, and capsules.

Apothecary Botanicals has been engaged to manufacture and distribute Yield Growth's 'Jack n Jane' products, combining Yield Growth's proprietary formulations with Apothecary Botanical's cannabis supply, services, facilities, equipment, and required Health Canada licenses for processing and sales. Yield Growth will supply all non-cannabis ingredients, packaging, and design while Apothecary Botanicals will supply cannabis containing THC and/or CBD as required for the various product formulations. The first phase of production is expected to include three tinctures containing THC and CBD, with a goal of coming to market by December 31, 2019.

Apothecary Botanicals CEO, David Eto, commented, "I'm very pleased that Apothecary Botanicals can leverage its manufacturing, formulation, and distribution capabilities to assist Yield Growth expand into the Canadian market. Our in-house expertise in the food & beverage sector will add tremendous value to cannabis brands entering the Edibles market worth an estimated C$2.7 billion annually in Canada alone. Our facilities are GMP-compliant and managed by food sector specialists who understand the importance of food safety and quality. Our business principles are grounded in building a transparent, cost effective, and trusting partnership that will create long lasting business relationships and positive experiences for customers who will consume edibles."

Geyser Brands CEO, Andreas Thatcher, commented, "The goal of Apothecary Botanicals is to deliver innovative formulations and high-quality manufacturing using cannabis as an ingredient. This LOI shows that we are delivering on both. As the new cannabis legislation comes into force, we are scaling our licensed production into beverages, edibles and cosmetics. Our experience in food and beverage, cosmetics, and GMP manufacturing provides a complete platform for brands to enter the Canadian cannabis market."

48North Cannabis Corp. (TSXV:NRTHannounced that it has signed an exclusive licensing agreement with U.S.-based APCNA Holdings LLC. ("Apothecanna"), to bring its best-selling, premium cannabis topicals brand to Canadian consumers.

Apothecanna, an established U.S cannabis brand focused on organic topical formulations, made without the use of artificial ingredients, fillers, parabens, or GMO ingredients, has been a leading topicals brand in the United States since its founding in 2009. Apothecanna has developed a suite of next-generation health and wellness cannabis products including, but not limited to: pain relief creams, a skincare line, sex oils, and other therapeutic cannabis-based topicals.

48North is focused on delivering best-in-class and innovative next-generation cannabis products to Canadian consumers. To that end, the Company strongly believes that value-added cannabis products that have succeeded in mature U.S markets, will also succeed in the Canadian marketplace. The agreement with Apothecanna, on the heels of the Company's previously announced licensing agreements with Avitas and Mother & Clone, builds on 48North's growing portfolio of popular U.S-based cannabis brands.

"Without question, Apothecanna is one of the leading topical cannabis brands in the United States. Since 2009, Apothecanna has led the charge in combating cannabis stigma through spreading the wisdom of traditional plant medicine. They have successfully formulated a suite of best-in-class health and wellness products and developed an industry-leading brand. We are so excited to announce that Apothecanna's products will soon be available for Canadian consumers," said Alison Gordon, CEO of 48North.

"Great partnerships require shared values, and, like us, 48North is all about innovation and performance. Their commitment to sustainability and all-natural ingredients gave us the confidence we needed to expand our business into Canada. We look forward to combining our formulations and expertise with 48North's high-quality outdoor cannabis with the vision of normalizing cannabis through sport with the help of Good:Farm and 48North," said James Kennedy, Founder and CEO, of Apothecanna.

Under the terms of the licensing agreement signed October 16, 2019, 48North will license Apothecanna intellectual property and manufacturing techniques for domestic consumption in Canada.

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPTannounced that it entered into an agreement to provide extraction services to a large U.S.-based farming services operation. Under the contract terms, Neptune will receive hemp biomass to be processed and transformed into crude oil extracts. The 2-year agreement could reach a total value in excess of US$20 million. The first shipment of biomass is expected to arrive at Neptune's North Carolina facility in the coming weeks.

"This large contract will support our capacity expansion at our North Carolina facility and better position us to serve the growing United States market. Our expansion in North Carolina is on time and on budget with extraction capacity expected to reach an annual run-rate of 1,500,000 kg of biomass by December 2019. Demand for extraction and formulation services in the U.S. is currently strong with the ongoing harvest season and our tolling and formulation pipeline to deliver high quality full and broad spectrum extracts remains robust. This announcement represents a further step towards our customer and geographic diversification strategy," said Michael Cammarata, Neptune's CEO.

Neptune also recently appointed Brett DuBose as Vice-President of Sales for the U.S. Region. Brett has more than 20 years of sales experience, most recently with Lonza Consumer Health and Nutrition where he was Associate Director Sales, for the Eastern U.S and Canada. He has also worked for 14 years at Pfizer in the Capsugel division, his last role being a Sales Manager Generic & Dietary Supplement. "With his extensive industry contacts and experience, Brett will play a key role in helping Neptune accelerate its market penetration in the U.S.," said Mr. Cammarata.

Once Neptune's near-term capacity expansion plans are complete and the Canadian expansion approved by Health Canada, the Company is expected to have a total extraction capacity of 3,000,000 kg of biomass annually, spread equally between Canada and the U.S.

SOL Global Investments Corp. (CSE: SOL) (OTC: SOLCFannounced that 3 Boys Farms, LLC , which owns and operates one of the original fourteen (14) medical marijuana treatment center licenses in Florida, will now operate under the business name "One Plant" after receiving the required regulatory approvals. SOL Global embraced the name One Plant for 3 Boys Farm and the Company's proposed dispensaries nationwide as the team firmly believes that just this "one" plant can solve countless problems. Chief Executive Officer Brady Cobb said "this One Plant can provide relief to patients suffering from so many debilitating conditions and illnesses and can help patients avoid dangerously addictive opioids, and this One Plant can also enhance and enrich patient's lives by giving them the freedom to enjoy daily life in a meaningful way." The name change comes as SOL Global accelerates its transition to a cannabis multi-state operator.

Additionally, One Plant is proud to announce that its proprietary delivery model, which launched in early July 2019, has shown tremendously positive results. From the launch in early July through October 3, 2019, One Plant, known for its best in class cannabis flower which is organically grown, has seen continued week over week delivery growth of 20% or more, week over week patient onboarding of 20% or more, and over a 300% increase in call volumes and orders from patients in Florida. During the week of October 4-10, 20191, One Plant's sales accelerated once it harvested and cured its first harvest after the previously announced operational upgrades were implemented at its Ruskin, Florida greenhouse facility. This harvest, which included One Plant's Ebony & Ivory strain which test results confirmed had a market leading THC content of 27%, resulted in One Plant sales increasing 140% week over week as compared to the previous reporting period. One Plant rose to 7th (out of 14 MMTC's) in flower sales in Florida, and 10th in overall sales in Florida, respectively1. What is more impressive is that One Plant achieved this increased sales volume all via its proprietary home delivery system, and without having a single dispensing location open.

"The fact we outsold our competitors, several of whom have over a dozen brick and mortar locations, is a testament to the power of our home delivery model," said CEO Brady Cobb. "With less capital expenditure, One Plant's efficiently scaled operations cut right to the bottom line. We are excited about opening up new strategically located stores that will serve as both retail dispensaries and prime delivery hubs to boost sales and EBITDA growth."
By the end of October 2019, One Plant is expected to open its first two (2) retail stores in Boynton Beach and Jacksonville Beach, respectively, with four (4) more locations anticipated for 2019.

Having just obtained Good Agricultural Practices-Farm (GAP) and Good Manufacturing Processing (GMP) approvals for its state-of-the-art cannabis cultivation facility in Ruskin, Florida, One Plant is positioned to become one of the United States' leading cannabis farms and distribution centers.

Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, announced the addition of four new dispensaries with openings in Maryland, Delaware and Florida.

Columbia Care’s facility in Chevy Chase represents the Company’s first dispensary in Maryland, a state with more than 100,000 registered patients and a market projected to reach sales in excess of $200 million by year end 2019. The facility’s proximity to Washington, D.C., Delaware, Virginia and Pennsylvania, all markets where Columbia Care operates, allows it to serve as one of the cornerstones for the Company’s mid-Atlantic strategy.

Columbia Care also opened its second dispensary in Delaware, located in Wilmington. With approximately 9,000 patients expected to be registered in the state’s medical program in 2019, Delaware lawmakers are expected to introduce adult use legislation in 2020, which could significantly increase patient access as well as the size of the total addressable market.

Finally, the Company has added two more dispensaries in Florida with the opening of its Sarasota and Jacksonville facilities, bringing the total number of dispensaries open in the state to three. With over 375,000 registered patients, Florida remains one of the largest medical cannabis markets in the world.

“No debt and a significant cash position gives Columbia Care one of the strongest balance sheets in the industry with access to the growth capital required to fund our 2019 strategic plan to operationalize all of our existing licenses,” said Nicholas Vita, chief executive officer of Columbia Care. “We are proud to execute on the plan we previously described to our investors, and by leveraging this strong foundation, we look forward to reaping the benefits of having one of the largest organically developed national cannabis platforms in the US. Opening these four additional dispensaries in key markets across the country represents significant progress and points to an accelerated pace of activity as we near the completion of this transformational year.”

The Company will offer the CNC Card, the nation’s first legal credit card for cannabis purchases, at each of these new locations. In addition, subject to regulatory approval, the company also intends to offer its proprietary home delivery service, “CC@Home,” which, together with the CNC Card, is designed to provide a convenient and comfortable guest experience as well as improved access to high-quality cannabis products capable of addressing a range of unmet health and wellness needs.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411

  



Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory